Popular Articles From: Sam’s Club Giving Program Awards $500,000 Grant to First Children’s Finance to Help Increase and Sustain High-Quality Child Care Businesses to CUSIP Global Services Marks Anniversary of JOBS Act with Fee-Waived CUSIP IDs for Crowdfunded Offerings


The Sam’s Club Giving Program today announced a $500,000 grant to First Children’s Finance (FCF) to provide finance and management assistance to child care businesses in low income communities.
Sign-up for Sam’s Club Giving Program Awards $500,000 Grant to First Children’s Finance to Help Increase and Sustain High-Quality Child Care Businesses investment picks
2014/8/5
One Path to Inner Peace is Getting Claims Paid Fast; Supplemental Insurance Can Help Alleviate the Stress of a Major Medical Emergency COLUMBUS, Ga.
Sign-up for The Aflac Duck Attempts Yoga In New Television Commercial investment picks
2014/8/4
GREENWICH, Conn.
Sign-up for Littlejohn & Co. Completes Sale of CoActive Technologies' DeltaTech Controls Unit investment picks
MENLO PARK, Calif., July 29, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT) , a commercial drug-device company committed to improving the quality of life for patients with ear, nose and throat conditions, today announced the closing of its initial public offering of 5,750,000 shares of its common stock at a public offering price of $11.00 per share, including 750,000 shares sold pursuant to the underwriters' option to purchase additional shares.
Sign-up for Intersect ENT Announces Closing of its Initial Public Offering investment picks
2014/9/17
Data shows recent plateau and drop in therapy utilization, but experts suggest new surge upon pending approval of new regimens Therapy discontinuation rates were nearly four times higher than in clinical trials, pointing to importance of focusing on medication adherence strategies CVS/Caremark specialty pharmacy support results in higher rates of medication adherence for patients undergoing therapy WOONSOCKET, R.I. , Sept.
Sign-up for CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies investment picks
2014/9/19
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1145955&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for FBC Inks Deal With COCO-AMO: LOVE, a Revolutionary Hair / Skin Care Company With Sales on Amazon investment picks
2014/9/23
Canon U.S.A., Inc., a leader in digital imaging solutions, announced today the PIXMA iP110 Wireless 1 Mobile Printer, designed for on-the-go business professionals who need a printer that can keep up with their ever-changing lifestyle.
Sign-up for Canon U.S.A. Announces PIXMA iP110 Mobile Printer for On-the-Go Business Professionals investment picks
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of Florida on behalf of purchasers of Ocwen Financial Corp.
Sign-up for SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Ocwen Financial Corp. To Contact Brower Piven Before The October 14, 2014 Lead Plaintiff Deadline In Class Action Lawsuit investment picks
2014/9/22
By Saumya Vaishampayan And Chris Dieterich U.S. stocks edged lower Monday, as downbeat signals from China helped push back the Dow Jones Industrial Average from last week's all-time high.
Sign-up for U.S. Stocks Open Lower investment picks
2014/9/22
High Five Featured as First-Ever, Fan-Inspired Character in Skylanders Trap Team™ PLANO, Texas , Sept.
Sign-up for Frito-Lay And Activision Announce $100,000 Scholarship Winner In Skylanders® "Choose And Name A New Hero" Promotion investment picks
2014/9/25
By Danny Yadron Google and Amazon raced Thursday to patch the latest hole in the Internet, after researchers discovered a bug in software that runs on up to 50% of all web servers and many Apple devices.
Sign-up for UPDATE: Google, Amazon respond to shellshock security flaw investment picks
WESTFORD, Mass.
Sign-up for Cynosure Promotes Chris Aronson to Vice President of North American Sales investment picks
Gilead Sciences, Inc. (Nasdaq:GILD) today announced results from the AMBITION study (a randomized, double-blind, multicenter study of first-line combination therapy with AMB r I sentan and T adalafil in patients with pulmonary arterial hypertens ION ), which was conducted in collaboration with GlaxoSmithKline (GSK). In AMBITION, first-line treatment of pulmonary arterial hypertension (PAH) with the combination of ambrisentan 10 mg and tadalafil 40 mg reduced the risk of clinical failure by 50 percent compared to the pooled ambrisentan and tadalafil monotherapy arm (hazard ratio = 0.502; 95 percent CI: 0.348, 0.724; p=0.0002). The combination was also statistically significant versus the individual ambrisentan and tadalafil monotherapy groups for the primary endpoint (p<0.01). Rates of serious adverse events and events leading to discontinuation were similar across treatment arms.
Sign-up for First-Line Combination of Ambrisentan and Tadalafil Reduces Risk of Clinical Failure Compared to Monotherapy in Pulmonary Arterial Hypertension Outcomes Study investment picks
2014/7/23
Clear Channel announced today the star-studded line-up for the 2014 iHeartRadio Music Festival, the legendary weekend-long concert event that re-writes radio history each year, taking place on September 19 and 20 in Las Vegas.
Sign-up for Clear Channel Announces Lineup for Two-Day Historic iHeartRadio Music Festival and the Return of the Daytime ‘iHeartRadio Music Festival Village’ investment picks
Retail clinics continue to play a growing and important role in health care delivery in the U.S., and a new research study from Walgreens (NYSE: WAG) (Nasdaq: WAG) shows patients are relying more on nurse practitioners at retail clinics to provide chronic and preventive health services.
Sign-up for More Patients Turning to Retail Clinics for Chronic Care and Preventive Services, New Walgreens Study Shows investment picks
Q3 non-GAAP revenue and non-GAAP EPS exceed guidance Company reports Q3 non-GAAP revenue growth of 28% BELLEVUE, Wash.
Sign-up for Concur Reports Results for Fiscal 2014 Third Quarter investment picks
ROCHESTER, N.Y., July 31, 2014 (GLOBE NEWSWIRE) -- Transcat, Inc. (Nasdaq:TRNS) ("Transcat" or the "Company"), a leading provider of accredited calibration and compliance services and distributor of professional grade handheld test, measurement and control instrumentation, announced today that the Company has agreed to terms on a three-year, $1.5 million contract to provide calibration and compliance services to a Life Science company headquartered in the Northeast U.S. The customer specializes in digital diagnostic tools and services to assist in better health decisions.
Sign-up for Transcat Agrees to Terms on $1.5 Million Calibration and Compliance Services Contract investment picks
Lincoln Financial Group (NYSE: LNC) today reported net income for the second quarter of 2014 of $398 million, or $1.48 per diluted share available to common stockholders, compared to net income in the second quarter of 2013 of $317 million, or $1.15 per diluted share available to common stockholders.
Sign-up for Lincoln Financial Group Reports Second Quarter 2014 Results investment picks
http://media.marketwire.com/attachments/201209/51143_calliduscloud_logo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1134229&ProfileId=051205&sourceType=1 PLEASANTON, CA --
Sign-up for AppDynamics Selects CallidusCloud to Optimize Sales Performance investment picks
Wynn Resorts, Limited (Nasdaq: WYNN) today reported financial results for the second quarter ended June 30, 2014.
Sign-up for Wynn Resorts, Limited Reports Second Quarter 2014 Results investment picks
Cryptography Research , the security division of Rambus (NASDAQ:RMBS), today announced that MStar Semiconductor, Inc., a leading semiconductor company for display and digital home solutions, has licensed the Cryptography Research CryptoFirewall ™ security core for integration into its connected TV solution chips.
Sign-up for MStar to Include Cryptography Research’s CryptoFirewall™ Security Core in Connected TV Chips investment picks
Exelis ( NYSE: XLS ) today announced that Senior Vice President and Chief Financial Officer Peter Milligan will present at the Cowen and Company 7 th Annual Global Transportation and Aerospace and Defense Conference on Thursday, Sept.
Sign-up for Exelis Senior Vice President and Chief Financial Officer Peter Milligan to present at Cowen and Company 7th Annual Global Transportation and Aerospace and Defense Conference investment picks
2014/9/25
The gap between the best and worst performing hedge funds has narrowed during the first half of 2014, BlackRock’s latest analysis of the hedge fund industry has found.
Sign-up for Gulf Narrows between Best and Worst Hedge Funds in 2014, BlackRock Research Finds investment picks
hhgregg (NYSE: HGG), leading appliance, electronics and furniture retailer, today announced the grand opening of a remodeled location in Columbus, Ohio’s Sawmill Shopping Center (6440 Sawmill Road). The store reopens to the public on Thursday, Sept.
Sign-up for hhgregg Hosts Grand Opening at Columbus, Ohio Store Location investment picks
2014/9/17
By Chiara Albanese U.S. bank State Street Corp.
Sign-up for State Street asks FX spot trading head to stay home investment picks
FREMONT, Calif.
Sign-up for Exar Completes Merger with Integrated Memory Logic investment picks
Nuance Communications, Inc. (NASDAQ: NUAN) today announced that ING Netherlands has turned to Nuance’s voice and artificial intelligence (AI) technologies to power Inge, the new voice feature of ING Netherlands’ mobile banking app .
Sign-up for ING Introduces a Voice-Controlled Mobile Banking App Powered by Nuance investment picks
2014/9/19
Locations Inside Select CVS/pharmacy stores in Five Locations WOONSOCKET, R.I. , Sept.
Sign-up for MinuteClinic Walk-in Medical Clinics Opening in Memphis investment picks
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the European Commission has granted marketing authorization for Zydelig ® (idelalisib), 150 mg tablets, a first-in-class oral treatment for two incurable blood cancers - chronic lymphocytic leukemia (CLL) and follicular lymphoma (FL). For the treatment of CLL, Zydelig has been approved for use in combination with rituximab for patients who have received at least one prior therapy; or as first-line treatment in the presence of 17p deletion or TP53 mutation in patients unsuitable for chemo-immunotherapy.
Sign-up for European Commission Grants Marketing Authorization for Gilead’s Zydelig® (Idelalisib) for the Treatment of Chronic Lymphocytic Leukemia and Follicular Lymphoma investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Popular Articles From: Sam’s Club Giving Program Awards $500,000 Grant to First Children’s Finance to Help Increase and Sustain High-Quality Child Care Businesses to CUSIP Global Services Marks Anniversary of JOBS Act with Fee-Waived CUSIP IDs for Crowdfunded Offerings
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices